SavedAdd your journal

Journals / Turkish Journal of Pediatrics / 2016 / Cilt: 58 - Sayı: 2

An unexpected diagnostic course of systemic lupus erythematosus

Aysel TAKTAK²
Adem KÖKSOY¹
Özge BAŞARAN
SABA KİREMİTCİ
BANU ÇELİKEL ACAR
Nermin UNCU
NİLGÜN ÇAKAR
Pages
223–226
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

At follow up his laboratory findings and general condition improved and no relapse was seen.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Taktak A, Köksoy A, Başaran Ö, Kiremitçi S, Acar B, Uncu N, Çakar N.
📊
Key Findings & Data:Turk J Pediatr 2016; 58: 223-226.Thrombotic microangiopathy (TM), especially thrombotic thrombocytopenic purpura (TTP) is described in systemic lupus erythematosus (SLE) as a severe hematological involvement.
💡
Conclusion & Impact:At follow up his laboratory findings and general condition improved and no relapse was seen.
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Özet

Taktak A, Köksoy A, Başaran Ö, Kiremitçi S, Acar B, Uncu N, Çakar N. An unexpected diagnostic course of systemic lupus erythematosus. Turk J Pediatr 2016; 58: 223-226.Thrombotic microangiopathy (TM), especially thrombotic thrombocytopenic purpura (TTP) is described in systemic lupus erythematosus (SLE) as a severe hematological involvement. However hemolytic uremic syndrome (HUS) is seen less frequently in SLE, particularly as an initial presentation. Here we present a 15-year old boy presenting with gross hematuria, decreased urinary output and petechial lesions. He was diagnosed as atypical HUS according to the classical triad of TM, along with observation of hypocomplementemia and negative stool cultures. In addition, his symptoms fulfilled the 2012 revised criteria for the classification of SLE. He was treated with plasma infusions and methylprednisolone/prednisone. At follow up his laboratory findings and general condition improved and no relapse was seen.

🔖

Cite This Article

TAKTAK², A., KÖKSOY¹, A., BAŞARAN, Ö., KİREMİTCİ, S., ACAR, B. Ç., UNCU, N., ÇAKAR, N. (2016). An unexpected diagnostic course of systemic lupus erythematosus. Turkish Journal of Pediatrics, Cilt: 58 - Sayı: 2, 223–226. https://ajindex.com/articles/412222

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Gasser C, Gautier E, Steck A, Siebenmann RE, Oechslin R. Hemolytic-uremic syndrome: bilaterale necrosis of the renal cortex in acquired hemolytic anemia. Schweiz Med Wochenschr 1955; 85: 905-909
  2. Trachtman H. HUS and TTP in children. Pediatr Clin North Am 2013; 60: 1513-1526
  3. Coppo P, Bengoufa D, Veyradier A, et al. Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement. Medicine (Baltimore) 2004; 83: 233-244
  4. Veyradier A, Obert B, Houllier A, Meyer D, Girma JP. Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases. Blood 2001; 98: 1765-1772
  5. Kawasaki Y, Suzuki J, Nozawa R, Suzuki S, Suzuki H. A 12-year-old girl with hemolytic uremic syndrome as initial symptom of systemic lupus erythematosus and a literature review. Am J Nephrol 2002; 22: 576-580
  6. Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64: 2677-2686
  7. Levy DM, Kamphuis S. Systemic lupus erythematosus in children and adolescents. Pediatr Clin North Am 2012; 59: 345-364
  8. Valentijn RM, van Overhagen H, Hazevoet HM, et al. The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 1985; 28: 904-913
  9. Song D, Wu LH, Wang FM, et al. The spectrum of renal thrombotic microangiopathy in lupus nephritis. Arthritis Res Ther 2013; 15: R12
  10. Goicoechea de Jorge E, Harris CL, Esparza-Gordillo J, et al. Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. Proc Natl Acad Sci USA 2007; 104: 240- 245
  11. Dragon-Durey MA, Loirat C, Cloarec S, et al. Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome. J Am Soc Nephrol 2005; 16: 555- 563
  12. Yu F, Tan Y, Zhao MH. Lupus nephritis combined with renal injury due to thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Nephrol Dial Transplant 2010; 25: 145-152
  13. Quintanilla-Flores DL, Hernadez-Coria MI, ElizondoRiojas G, Galarza-Delgado DA, Gonzalez-Gonzalez J, Tamez-Perez HE. Thyroid nodules in Hispanic patients with systemic lupus erythematosus. Lupus 2013; 22: 1509-1513.